Pennant Group, Inc. (PNTG) Form 8-K — Aug 5, 2026

$PNTGForm 8-KItems 2.02, 7.01, 9.01Filed Aug 5, 2026, 4:16 PM ET0001766400-26-000064Original filing

The Pennant Group (Nasdaq: PNTG) reported Q2 2026 revenue of $298.0 million, up 35.8% year over year, with GAAP diluted EPS of $0.25 (vs $0.20) and adjusted diluted EPS of $0.36 (vs $0.27). Net income attributable to the company rose 28.2% to $9.1 million and consolidated adjusted EBITDA rose 48.2% to $24.3 million. Growth was led by the home health and hospice segment, where revenue jumped 43.2% to $237.8 million and total home health admissions rose 62.3%, driven largely by recently acquired southeast operations. Senior living revenue grew 12.6% to $60.2 million, with same-store occupancy up 150 basis points to 81.6%.

Key figures

Eps: $0.25 GAAP diluted (vs $0.20 prior year quarter)
Revenue: $298.0 million (Q2 2026)
Guidance: FY2026: revenue $1,171.1-$1,190.1 million; adjusted diluted EPS $1.34-$1.41; adjusted EBITDA $94.4-$98.0 million; adjusted EBITDA prior to NCI $101.5-$105.1 million (based on ~37.0 million diluted shares, 26.0% tax rate, no unannounced acquisitions)
Net Income: $9.1 million attributable to Pennant (+28.2% YoY); consolidated net income $10.9 million
Total Debt: $197.5 million ($192.5 million long-term + $5.0 million current maturities)
Revenue Yoy: +35.8% (+$78.5 million)
Total Assets: $1,037.3 million at June 30, 2026
Cash Position: $15.3 million at June 30, 2026
Shares Outstanding: 35.08 million issued and outstanding at June 30, 2026; 35.957 million diluted weighted average in Q2
Hospice adc growth: +40.1% YoY
Adjusted net income: $12.8 million (+36.5% YoY)
Interest expense q2: $3.3 million (vs $1.2 million prior year quarter)
Adjusted diluted eps: 0.36
Senior living revenue: $60.2 million (+12.6% YoY)
Senior living occupancy: 78.9%
Home health hospice revenue: $237.8 million (+43.2% YoY)
Consolidated adjusted ebitda: $24.3 million (+48.2% YoY)
Hospice average daily census: 5477
Total home health admissions: 28947
Consolidated adjusted ebitdar: $37.6 million
Prior year adjusted diluted eps: 0.27
Same store senior living occupancy: 81.6% (+150 bps YoY)
Transition services agreement fees: $2.5 million (Q2) / $5.3 million (six months)
Total home health admissions growth: +62.3% YoY
Avg monthly revenue per occupied room: $5,392
Same store home health admissions growth: +9.7% YoY
Consolidated adjusted ebitda prior to nci: $26.1 million (+51.0% YoY)
Fy2026 revenue from former unitedhealth amedisys assets: $196.0-$198.0 million

Price after filing

1 day: 0.0%7 days: -0.6%30 days: -0.2%

Close on the filing date to close N calendar days later (from $38.61). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.